Effect of meal size and composition on the bioavailability of ketoprofen (Oruvail). 1987

J G Nievel, and C W Havard, and P Mitchell, and A Gudgeon, and C M Kaye

Seven young male volunteers received a single oral dose of Oruvail (ketoprofen 200 mg capsule) on two occasions, immediately after either a light/lean or a heavy/fatty meal at breakfast time. Administration of ketoprofen immediately following the heavy meal slightly, but significantly, delayed the absorption of the drug, as evidenced by mean (+/- S.D.)Tmax values of 6.7 (+/- 1.0) and 9.0 (+/- 1.4) hours respectively. Changing the type of meal had no statistically significant effect on the maximum plasma level, apparent plasma elimination half-life (t 1/2 h), area under the plasma level versus time curve, total plasma clearance, and urinary recovery of total ketoprofen, indicating that the bioavailability (and the systemic level) of ketoprofen was not affected by meal composition.

UI MeSH Term Description Entries
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D007660 Ketoprofen An IBUPROFEN-type anti-inflammatory analgesic and antipyretic. It is used in the treatment of rheumatoid arthritis and osteoarthritis. Benzoylhydratropic Acid,19,583 RP,2-(3-Benzoylphenyl)propionic Acid,Alrheumat,Alrheumum,Orudis,Profenid,RP-19583,RP 19583,RP, 19,583,RP19583
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D010666 Phenylpropionates Derivatives of 3-phenylpropionic acid, including its salts and esters.
D002149 Energy Intake Total number of calories taken in daily whether ingested or by parenteral routes. Caloric Intake,Calorie Intake,Intake, Calorie,Intake, Energy
D004041 Dietary Fats Fats present in food, especially in animal products such as meat, meat products, butter, ghee. They are present in lower amounts in nuts, seeds, and avocados. Fats, Dietary,Dietary Fat,Fat, Dietary
D005502 Food Substances taken in by the body to provide nourishment. Foods
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J G Nievel, and C W Havard, and P Mitchell, and A Gudgeon, and C M Kaye
December 1992, Journal of clinical pharmacology,
J G Nievel, and C W Havard, and P Mitchell, and A Gudgeon, and C M Kaye
July 1986, Clinical and experimental pharmacology & physiology,
J G Nievel, and C W Havard, and P Mitchell, and A Gudgeon, and C M Kaye
November 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
J G Nievel, and C W Havard, and P Mitchell, and A Gudgeon, and C M Kaye
April 2000, The American journal of clinical nutrition,
J G Nievel, and C W Havard, and P Mitchell, and A Gudgeon, and C M Kaye
April 1993, Behavioral neuroscience,
J G Nievel, and C W Havard, and P Mitchell, and A Gudgeon, and C M Kaye
May 1999, Pharmaceutical research,
J G Nievel, and C W Havard, and P Mitchell, and A Gudgeon, and C M Kaye
November 2014, Appetite,
J G Nievel, and C W Havard, and P Mitchell, and A Gudgeon, and C M Kaye
December 1991, Transplantation,
J G Nievel, and C W Havard, and P Mitchell, and A Gudgeon, and C M Kaye
November 1991, The American journal of clinical nutrition,
J G Nievel, and C W Havard, and P Mitchell, and A Gudgeon, and C M Kaye
March 1986, British journal of clinical pharmacology,
Copied contents to your clipboard!